Wataru Nakata

Chuo, 5400008, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Journal: Japanese journal of clinical oncology

Published: May 27, 2026

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Journal: Japanese journal of clinical oncology

Published: May 11, 2026

A Case of Long-Term Complete Remission by Pembrolizumab＋Axitinib, Cabozantinib for Papillary Renal Cell Carcinoma with Metastasis

A Case of Long-Term Complete Remission by Pembrolizumab＋Axitinib, Cabozantinib for Papillary Renal Cell Carcinoma with Metastasis

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: October 01, 2025

A Case of Venous Leiomyosarcoma of the Inferior Vena Cava Diagnosed Preoperatively as an Adrenal Tumor

A Case of Venous Leiomyosarcoma of the Inferior Vena Cava Diagnosed Preoperatively as an Adrenal Tumor

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: April 14, 2025

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Journal: International journal of clinical oncology

Published: June 23, 2024

OSTEOMYELITIS PUBIS AFTER RETROPERITONEOSCOPIC RADICAL PROSTATECTOMY TRIGGERED BY EXERCISE: A CASE REPORT

OSTEOMYELITIS PUBIS AFTER RETROPERITONEOSCOPIC RADICAL PROSTATECTOMY TRIGGERED BY EXERCISE: A CASE REPORT

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 01, 2024

PROGNOSTIC FACTORS FOR METASTATIC UROTHELIAL CARCINOMA IN THE IMMUNOTHERAPY ERA

PROGNOSTIC FACTORS FOR METASTATIC UROTHELIAL CARCINOMA IN THE IMMUNOTHERAPY ERA

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 01, 2024

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Journal: Japanese journal of clinical oncology

Published: October 09, 2023

A Case of Prostate Cancer Diagnosed by the Bone Biopsy of the Right Iliac Metastatic Lesion

A Case of Prostate Cancer Diagnosed by the Bone Biopsy of the Right Iliac Metastatic Lesion

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: August 09, 2023

Preoperative Immunonutrition Significantly Reduced Surgical Site Infection After Urinary Diversion for Invasive Bladder Cancer: A Retrospective Cohort Study.

Preoperative Immunonutrition Significantly Reduced Surgical Site Infection After Urinary Diversion for Invasive Bladder Cancer: A Retrospective Cohort Study.

Journal: Clinical genitourinary cancer

Published: June 17, 2023

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

Journal: International journal of clinical oncology

Published: April 17, 2022

A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.

A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 02, 2022

Showing 1-12 of 49

Last Updated: 09/26/2026